NZ600453A - Inhibitors of akt activity - Google Patents
Inhibitors of akt activityInfo
- Publication number
- NZ600453A NZ600453A NZ600453A NZ60045310A NZ600453A NZ 600453 A NZ600453 A NZ 600453A NZ 600453 A NZ600453 A NZ 600453A NZ 60045310 A NZ60045310 A NZ 60045310A NZ 600453 A NZ600453 A NZ 600453A
- Authority
- NZ
- New Zealand
- Prior art keywords
- inhibitors
- akt activity
- formula
- pharmaceutical compositions
- serine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0922589.7A GB0922589D0 (en) | 2009-12-23 | 2009-12-23 | Pharmaceutical compounds |
| PCT/GB2010/002329 WO2011077098A1 (en) | 2009-12-23 | 2010-12-23 | Inhibitors of akt activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ600453A true NZ600453A (en) | 2013-10-25 |
Family
ID=41716932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ600453A NZ600453A (en) | 2009-12-23 | 2010-12-23 | Inhibitors of akt activity |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9221838B2 (https=) |
| EP (1) | EP2516435B8 (https=) |
| JP (1) | JP5923043B2 (https=) |
| KR (1) | KR20140015157A (https=) |
| CN (1) | CN102791708B (https=) |
| AU (1) | AU2010334591C1 (https=) |
| BR (1) | BR112012015677A2 (https=) |
| CA (1) | CA2783340C (https=) |
| CY (1) | CY1115686T1 (https=) |
| DK (1) | DK2516435T3 (https=) |
| ES (1) | ES2503794T3 (https=) |
| GB (1) | GB0922589D0 (https=) |
| IL (1) | IL220153A (https=) |
| MX (1) | MX2012007274A (https=) |
| NZ (1) | NZ600453A (https=) |
| PL (1) | PL2516435T3 (https=) |
| PT (1) | PT2516435E (https=) |
| RU (1) | RU2579513C2 (https=) |
| SG (1) | SG181517A1 (https=) |
| SI (1) | SI2516435T1 (https=) |
| WO (1) | WO2011077098A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201205164D0 (en) | 2012-03-23 | 2012-05-09 | Almac Discovery Ltd | Pharmaceutical compounds |
| CA2971763A1 (en) * | 2014-12-23 | 2016-06-30 | Bergenbio Asa | Inhibitors of akt kinase |
| CN111943962A (zh) * | 2015-02-27 | 2020-11-17 | 大鹏药品工业株式会社 | 咪唑并噁嗪晶体、含有所述晶体的药物组合物和制备所述晶体的方法 |
| GB201603779D0 (en) | 2016-03-04 | 2016-04-20 | Mission Therapeutics Ltd | Novel compounds |
| US11208478B2 (en) | 2016-08-07 | 2021-12-28 | The Wistar Institute Of Anatomy And Biology | Methods of detecting and treating a tumor expressing pT346 PDK1 |
| PE20200696A1 (es) * | 2017-06-22 | 2020-06-16 | Curadev Pharma Ltd | Moduladores de moleculas pequenas de sting humana |
| KR102917509B1 (ko) | 2017-09-07 | 2026-01-26 | 오거스타 유니버시티 리서치 인스티튜트, 인크. | 특이적 akt3 활성제 및 이의 용도 |
| GB2600384A (en) * | 2020-09-30 | 2022-05-04 | Vaderis Therapeutics Ag | Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia |
| WO2025250545A1 (en) * | 2024-05-28 | 2025-12-04 | Alterome Therapeutics, Inc. | Akt1 modulators |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT76853A (en) * | 1994-11-14 | 1997-12-29 | Warner Lambert Co | 6-aryl pyrido[2,3-d]pyrimidines and naphthyridines for inhibiting protein tyrosine kinase mediated cellular proliferation and pharmaceutical compositions containing the same |
| TWI301760B (en) * | 2004-02-27 | 2008-10-11 | Merz Pharma Gmbh & Co Kgaa | Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| US7910561B2 (en) * | 2004-12-15 | 2011-03-22 | Merck Sharp & Dohme Corp. | Inhibitors of Akt activity |
| US8008317B2 (en) * | 2005-06-10 | 2011-08-30 | Merck Sharp & Dohme Corp. | Inhibitors of akt activtiy |
| CA2656507C (en) * | 2006-07-17 | 2012-03-20 | Amgen Inc. | Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| JP2010512312A (ja) | 2006-12-06 | 2010-04-22 | メルク エンド カムパニー インコーポレーテッド | Ａｋｔ活性の阻害剤 |
| AR064010A1 (es) | 2006-12-06 | 2009-03-04 | Merck & Co Inc | Inhibidores de la actividad de la akt |
| US7999107B2 (en) * | 2007-01-31 | 2011-08-16 | Merck Sharp & Dohme Corp. | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
| CA2726317A1 (en) | 2008-06-03 | 2009-12-10 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| EP2299825B1 (en) | 2008-06-03 | 2013-07-31 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
-
2009
- 2009-12-23 GB GBGB0922589.7A patent/GB0922589D0/en not_active Ceased
-
2010
- 2010-12-23 ES ES10800980.4T patent/ES2503794T3/es active Active
- 2010-12-23 SG SG2012041232A patent/SG181517A1/en unknown
- 2010-12-23 RU RU2012131115/04A patent/RU2579513C2/ru not_active IP Right Cessation
- 2010-12-23 EP EP10800980.4A patent/EP2516435B8/en active Active
- 2010-12-23 SI SI201030774T patent/SI2516435T1/sl unknown
- 2010-12-23 DK DK10800980.4T patent/DK2516435T3/da active
- 2010-12-23 AU AU2010334591A patent/AU2010334591C1/en not_active Ceased
- 2010-12-23 BR BRBR112012015677-2A patent/BR112012015677A2/pt not_active Application Discontinuation
- 2010-12-23 WO PCT/GB2010/002329 patent/WO2011077098A1/en not_active Ceased
- 2010-12-23 KR KR1020127019033A patent/KR20140015157A/ko not_active Ceased
- 2010-12-23 CA CA2783340A patent/CA2783340C/en not_active Expired - Fee Related
- 2010-12-23 MX MX2012007274A patent/MX2012007274A/es active IP Right Grant
- 2010-12-23 PT PT108009804T patent/PT2516435E/pt unknown
- 2010-12-23 US US13/517,219 patent/US9221838B2/en active Active
- 2010-12-23 JP JP2012545434A patent/JP5923043B2/ja active Active
- 2010-12-23 PL PL10800980T patent/PL2516435T3/pl unknown
- 2010-12-23 NZ NZ600453A patent/NZ600453A/xx not_active IP Right Cessation
- 2010-12-23 CN CN201080059321.9A patent/CN102791708B/zh active Active
-
2012
- 2012-06-04 IL IL220153A patent/IL220153A/en not_active IP Right Cessation
-
2014
- 2014-10-31 CY CY20141100899T patent/CY1115686T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102791708B (zh) | 2016-03-02 |
| HK1171013A1 (en) | 2013-03-15 |
| US9221838B2 (en) | 2015-12-29 |
| CY1115686T1 (el) | 2017-01-25 |
| WO2011077098A9 (en) | 2012-04-19 |
| IL220153A0 (en) | 2012-07-31 |
| PT2516435E (pt) | 2014-11-13 |
| CA2783340C (en) | 2015-11-24 |
| RU2012131115A (ru) | 2014-01-27 |
| MX2012007274A (es) | 2012-10-03 |
| EP2516435B1 (en) | 2014-08-06 |
| BR112012015677A2 (pt) | 2015-06-30 |
| CN102791708A (zh) | 2012-11-21 |
| JP2013515710A (ja) | 2013-05-09 |
| AU2010334591B2 (en) | 2014-04-10 |
| SG181517A1 (en) | 2012-07-30 |
| AU2010334591A1 (en) | 2012-06-21 |
| JP5923043B2 (ja) | 2016-05-24 |
| GB0922589D0 (en) | 2010-02-10 |
| CA2783340A1 (en) | 2011-06-30 |
| US20130116243A1 (en) | 2013-05-09 |
| IL220153A (en) | 2015-05-31 |
| WO2011077098A1 (en) | 2011-06-30 |
| PL2516435T3 (pl) | 2015-01-30 |
| EP2516435B8 (en) | 2014-10-15 |
| AU2010334591C1 (en) | 2014-07-31 |
| ES2503794T3 (es) | 2014-10-07 |
| KR20140015157A (ko) | 2014-02-06 |
| SI2516435T1 (sl) | 2014-12-31 |
| RU2579513C2 (ru) | 2016-04-10 |
| DK2516435T3 (da) | 2014-10-13 |
| EP2516435A1 (en) | 2012-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011033265A8 (en) | Pharmaceutical compounds | |
| NZ600453A (en) | Inhibitors of akt activity | |
| MX2011009796A (es) | Inhibidores de la cinasa pi3. | |
| MX340402B (es) | Inhibidores triciclicos de cinasas. | |
| MX2011011335A (es) | Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina. | |
| PH12016501048A1 (en) | Piperidine derivatives as mdm2 inhibitors for the treatment of cancer | |
| MX2012000711A (es) | Inhibidores de pirrolopirazina de cinasas. | |
| MX2012000709A (es) | Inhibidores de pirrolopiridina de cinasas. | |
| GEP20146146B (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
| MX2012013197A (es) | Inhibidores de indazol de cinasa. | |
| WO2010008847A3 (en) | Pi3k/m tor inhibitors | |
| TN2012000578A1 (en) | Tetrahydro-pyrido-pyrimidine derivatives | |
| MY164776A (en) | Heterocyclic compound | |
| MX352672B (es) | Compuestos heterocíclicos como inhibidores de mdm2 para el tratamiento del cáncer. | |
| UA111161C2 (uk) | Похідна фталазинонкетону, спосіб її одержання та її фармацевтичне застосування | |
| TN2014000016A1 (en) | 4 - piperidinyl compounds for use as tankyrase inhibitors | |
| MX2011005934A (es) | Compuestos organicos. | |
| HK1210174A1 (en) | Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases | |
| PH12015500211B1 (en) | 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes | |
| IN2012DN02139A (https=) | ||
| MX2012004780A (es) | Inhibidores de akt. | |
| WO2010150211A3 (en) | Use of derivatives of indoles for the treatment of cancer | |
| MX360330B (es) | Regimen de administracion para nitrocatecoles. | |
| IN2012DN03846A (https=) | ||
| MX2009003793A (es) | Inhibidores de cinasa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 DEC 2015 BY LEA Effective date: 20141203 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 DEC 2016 BY LEA SKYLLERSTEDT Effective date: 20151210 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 DEC 2017 BY CPA GLOBAL (PATRAFEE) Effective date: 20161208 |
|
| LAPS | Patent lapsed |